- Home
- BPMC vs VVV Comparison
BPMC vs VVV Comparison
Compare BPMC & VVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- VVV
- Stock Information
- Founded
- BPMC 2008
- VVV 1866
- Country
- BPMC United States
- VVV United States
- Employees
- BPMC N/A
- VVV N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- VVV Major Chemicals
- Sector
- BPMC Health Care
- VVV Industrials
- Exchange
- BPMC Nasdaq
- VVV Nasdaq
- Market Cap
- BPMC 8.3B
- VVV 4.3B
- IPO Year
- BPMC 2015
- VVV 2016
- Fundamental
- Price
- BPMC $128.42
- VVV $39.20
- Analyst Decision
- BPMC Buy
- VVV Buy
- Analyst Count
- BPMC 20
- VVV 12
- Target Price
- BPMC $127.82
- VVV $42.75
- AVG Volume (30 Days)
- BPMC 3.5M
- VVV 2.1M
- Earning Date
- BPMC 07-31-2025
- VVV 08-06-2025
- Dividend Yield
- BPMC N/A
- VVV N/A
- EPS Growth
- BPMC N/A
- VVV 56.15
- EPS
- BPMC N/A
- VVV 2.05
- Revenue
- BPMC $562,121,000.00
- VVV $1,674,400,000.00
- Revenue This Year
- BPMC $44.46
- VVV $6.67
- Revenue Next Year
- BPMC $32.78
- VVV $15.40
- P/E Ratio
- BPMC N/A
- VVV $19.08
- Revenue Growth
- BPMC 99.19
- VVV 9.56
- 52 Week Low
- BPMC $73.04
- VVV $31.02
- 52 Week High
- BPMC $128.75
- VVV $48.27
- Technical
- Relative Strength Index (RSI)
- BPMC 74.76
- VVV 63.91
- Support Level
- BPMC $128.06
- VVV $36.41
- Resistance Level
- BPMC $128.78
- VVV $39.90
- Average True Range (ATR)
- BPMC 0.26
- VVV 0.86
- MACD
- BPMC -1.13
- VVV 0.12
- Stochastic Oscillator
- BPMC 53.85
- VVV 81.48
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living with systemic mastocytosis (SM) and PDGFRA Exon 18 mutant GIST in the U.S. and Europe. The company also has various other drug candidates in its pipeline such as BLU-808, BLU-222, BLU-956, and others that are being developed to treat mast cell diseases including SM and chronic urticaria, breast cancer, and other solid tumors. Geographically, it operates in the United States, which is its key revenue market, and Europe.
About VVV Valvoline Inc.
Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.